Akari Therapeutics (AKTX) Shareholder's Equity Growth (1y) (2012 - 2026)
Akari Therapeutics (AKTX) Shareholder's Equity Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.87% |
| Dec 31, 2025 | 27.44% |
| Sep 30, 2025 | 438.92% |
| Jun 30, 2025 | 791.47% |
| Mar 31, 2025 | 712.05% |
| Dec 31, 2024 | 9,806.99% |
| Sep 30, 2024 | -3,242.72% |
| Jun 30, 2024 | -233.15% |
| Mar 31, 2024 | -154.15% |
| Dec 31, 2023 | -112.79% |
| Dec 31, 2022 | -67.76% |
| Dec 31, 2021 | -40.81% |
| Dec 31, 2020 | 123,410.38% |
| Sep 30, 2020 | 41.73% |
| Jun 30, 2020 | 1,196.87% |
| Mar 31, 2020 | -32.49% |
| Dec 31, 2019 | -99.83% |
| Dec 31, 2018 | -80.35% |
| Dec 31, 2017 | -34.80% |
| Dec 31, 2016 | -30.00% |